Evidence map›Paper›PMID 36751557›Full record

ArticleChina CDC weekly2022

Characteristics and Containment of 74 Imported COVID-19 Outbreaks: Experiences, Lessons, and Implications - China, 2020-2021.

Fuxiao Li, Chang Wei, Bingli Li, Tengfei Lin, Yiwen Jiang, Di Liu, Zhirong Yang, Zuyao Yang, Feng Sha, Jinling Tang

Abstract read
In one paragraph

Article in China CDC weekly, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fuxiao LiShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen City, Guangdong Province, China.
Chang WeiShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen City, Guangdong Province, China.
Bingli LiShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen City, Guangdong Province, China.
Tengfei LinShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen City, Guangdong Province, China.
Yiwen JiangShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen City, Guangdong Province, China.
Di LiuShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen City, Guangdong Province, China.
Zhirong YangShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen City, Guangdong Province, China.
Zuyao YangDivision of Epidemiology, JC School of Public Health and Primary Care, the Chinese University of Hong Kong, Hong Kong Special Administrate Region, China.
Feng ShaShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen City, Guangdong Province, China.
Jinling TangShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen City, Guangdong Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

What is already known about this topic?: After the initial coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China, the outbreaks during the dynamic-zero policy period in the mainland of China have not been systematically documented. What is added by this report?: We summarized the characteristics of 74 imported COVID-19 outbreaks between March 19, 2020 and December 31, 2021. All outbreaks of early severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants were successfully contained with the aid of nucleic acid testing, modern communication technologies, and non-pharmacological interventions. What are the implications for public health practice?: These findings provide us with confidence for the containment of future emerging infectious diseases alike at early stages to prevent pandemics or to win time to gain experience, develop vaccines and drugs, vaccinate people, and wait for the possible lessening of the virus' pathogenicity.

Indexed as

Containment strategyCOVID-19Outbreak elimination

Identifiers

PMID36751557
PMCPMC9897970

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.